Cargando…

Insurance Type Influences Access to Biologics and Healthcare Utilization in Pediatric Crohn’s Disease

BACKGROUND: The objective of this study is to determine if there is an association between insurance status and access to biologics among children with Crohn’s disease (CD). Additionally, we seek to determine differences in healthcare utilization between these groups, utilizing a national sample of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quiros, Jose Antonio, Andrews, Annie Lintzenich, Brinton, Daniel, Simpson, Kit, Simpson, Annie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802312/ https://www.ncbi.nlm.nih.gov/pubmed/36776668 http://dx.doi.org/10.1093/crocol/otab057

Ejemplares similares

The Impact of Timing on Clinical and Economic Outcomes During Inter-ICU Transfer of Acute Respiratory Failure Patients: Time and Tide Wait for No One
por: Nadig, Nandita R., et al.
Publicado: (2022)

Access to biologicals in Crohn’s disease in ten European countries
por: Péntek, Márta, et al.
Publicado: (2017)

Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn’s disease
por: Gupta, Neera, et al.
Publicado: (2018)

Elevated Driving Pressure and Elastance Does Not Increase In-Hospital Mortality Among Obese and Severely Obese Patients With Ventilator Dependent Respiratory Failure
por: Terry, Charles, et al.
Publicado: (2022)

Driving Pressure, Elastance, and Outcomes in a Real-World Setting: A Bi-Center Analysis of Electronic Health Record Data
por: Goodwin, Andrew J., et al.
Publicado: (2023)

Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents
por: Pilon, Dominic, et al.
Publicado: (2022)

Fungal dysbiosis predicts the diagnosis of pediatric Crohn’s disease
por: El Mouzan, Mohammad I, et al.
Publicado: (2018)

Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn’s Disease Receiving Biologics: A Retrospective Cohort Study
por: Hunter, Theresa, et al.
Publicado: (2022)

Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn’s Disease
por: Dulai, Parambir S, et al.
Publicado: (2022)

Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn’s Disease: A Retrospective Claims Database Analysis
por: Ungaro, Ryan C, et al.
Publicado: (2022)

Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients
por: Foster, Alice Jane, et al.
Publicado: (2019)

Intestinal dysbiosis in pediatric Crohn's disease patients with IL10RA mutations
por: Xue, Ai-Juan, et al.
Publicado: (2020)

Intestinal complications in patients with Crohn’s disease in the Brazilian public healthcare system between 2011 and 2020
por: Sassaki, Ligia Yukie, et al.
Publicado: (2023)

Healthcare utilization and costs associated with gastroparesis
por: Wadhwa, Vaibhav, et al.
Publicado: (2017)

Trends in Surgical Recurrence Among Pediatric Crohn’s Disease Patients Using Administrative Claims Data
por: Egberg, Matthew D, et al.
Publicado: (2023)

Adolescent Suicide—Understanding Unique Risks and Opportunities for Trauma Centers to Recognize, Intervene, and Prevent a Leading Cause of Death
por: Hink, Ashley B., et al.
Publicado: (2022)

Persistence, Dosing, and Other Treatment Patterns Among Crohn’s Disease Patients Initiating Biologics in United States
por: Teeple, Amanda, et al.
Publicado: (2021)

Safety and Effectiveness of Ustekinumab for Crohn’s Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed
por: Nagano, Katsumasa, et al.
Publicado: (2023)

Vedolizumab in Mild-to-Moderate Crohn’s Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study
por: Dotti, Adriana Zanoni, et al.
Publicado: (2023)

Assessing disease activity using the pediatric Crohn’s disease activity index: Can we use subjective or objective parameters alone?
por: Grant, Amy, et al.
Publicado: (2021)

Chronic opioids in gastroparesis: Relationship with gastrointestinal symptoms, healthcare utilization and employment
por: Jehangir, Asad, et al.
Publicado: (2017)

Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes
por: Nene, Sofia, et al.
Publicado: (2020)

Management Decisions in Crohn’s Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels
por: Wu, Yang, et al.
Publicado: (2021)

Palliative Care Utilization Following Out-of-Hospital Cardiac Arrest in Pediatrics
por: Gouda, Suzanne R., et al.
Publicado: (2022)

A Decade of Waiting: Experiences of Women Living With Vulvar Crohn’s Disease and Interactions With Healthcare Professionals Related to Their Sexual Well-Being: A Qualitative Study
por: Fourie, Simona, et al.
Publicado: (2023)

Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease
por: Chanchlani, Neil, et al.
Publicado: (2023)

Access to smart devices and utilization of online health resources among older cardiac rehabilitation participants
por: Saadi, Abdulghani, et al.
Publicado: (2020)

Utilization of access to colorectal cancer screening modalities in low-income populations after medicaid expansion
por: Fletcher, Gerald, et al.
Publicado: (2023)

Heterogeneity among Clinical Intestinal Escherichia coli Isolates upon Acquired Streptomycin Resistance
por: Lopez, Lacey R., et al.
Publicado: (2023)

A Novel Capsule Endoscopic Score for Crohn’s Disease
por: Omori, Teppei, et al.
Publicado: (2020)

The Impact of Confounders on Symptom–Endoscopic Discordances in Crohn’s Disease
por: Rajan, Anjana, et al.
Publicado: (2023)

Dynamic Delirium Severity Trajectories and Their Association With 2-Year Healthcare Utilization and Mortality Outcomes
por: Lindroth, Heidi, et al.
Publicado: (2021)

Characteristics of Long-Stay Patients in a PICU and Healthcare Resource Utilization After Discharge
por: Boerman, Gerharda H., et al.
Publicado: (2023)

Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
por: Sollelis, Elisa, et al.
Publicado: (2019)

Physical Activity in Adults With Crohn’s Disease: A Scoping Review
por: Neal, Whitney N, et al.
Publicado: (2022)

Quality indicators for Bariatric Surgery 2004 to 2012: example from Florida
por: Simpson, Annie N, et al.
Publicado: (2014)

Health-related quality of life in older adults: Effects of hearing loss and common chronic conditions
por: Simpson, Annie N., et al.
Publicado: (2015)

The Cost of Medicaid Savings: The Potential Detrimental Public Health Impact of Neonatal Circumcision Defunding
por: Andrews, Annie L., et al.
Publicado: (2012)

Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis
por: Seo, Hyungil, et al.
Publicado: (2017)

Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers
por: Wohnhaas, Christian T, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_59v94h0bnruhflnemv8snsahp4